Skip to content

Feasibility and Effectiveness of Therapy Together

Feasibility and Effectiveness of Therapy Together: An Intensive Upper Limb Therapy Program for Young Children With Cerebral Palsy and Their Caregivers

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07225673
Enrollment
37
Registered
2025-11-07
Start date
2020-01-02
Completion date
2026-09-30
Last updated
2025-11-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral Palsy

Brief summary

this study proposes to compare the feasibility and effectiveness of 2 methods of delivery of Therapy Together, a caregiver and child intensive upper limb therapy program for children with CP and children at risk for developing CP ages 3 months - 4 years 11 months.

Detailed description

One group will complete 32 hours onsite (4 hour weekly sessions) and 30 minutes of therapeutic activity at home, and the second group will complete 8 hours onsite and 1 hour of therapeutic activity at home. Both groups will aim to complete 56 hours of the intervention. The Therapy Together program includes caregiver education and coaching on implementing therapeutic activities that are play-based, age-appropriate, and tailored to meet goals to improve arm/hand function. The child and caregiver complete 8 coaching sessions. The first 7 intervention visits focus on constraint-induced movement therapy (CIMT) and the final intervention visit focuses on bimanual therapy (use of two hands).

Interventions

BEHAVIORALTherapy Together - 4 hour group

a caregiver partnered constraint induced movement therapy program

BEHAVIORALTherapy Together - 1 hour group

a caregiver partnered constraint induced movement therapy program

Sponsors

Texas Scottish Rite Hospital for Children
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
3 Months to 59 Months
Healthy volunteers
No

Inclusion criteria

* present with asymmetric hand * at risk for developing CP or children that have been diagnosed with CP * must be able to visually attend to objects * demonstrate an interest in objects * attempt to reach for or grasp them with the impaired upper extremity

Exclusion criteria

* uncontrolled epilepsy * significant visual impairment * severe behavioral problems * inability to complete the assessment protocol

Design outcomes

Primary

MeasureTime frameDescription
Mini-Assisting Hand Assessmentpre-intervention (within 2 weeks of start of intervention), and within 2 weeks of post-intervention]The Mini-Assisting Hand Assessment is an observation-based, criterion-referenced assessment that assesses bimanual hand function for children with cerebral palsy aged 8-18 months (measured in logits/units)
Assisting Hand Assessmentpre-intervention (within 2 weeks of start of intervention), and within 2 weeks of post-interventionThe Assisting Hand Assessment is an observation-based, criterion-referenced assessment that assess bimanual hand function for children with cerebral palsy, aged 18 months-12 years (measured in logits/units)

Secondary

MeasureTime frameDescription
Canadian Occupational Performance Measurepre-intervention (within 2 weeks of start of intervention), and within 2 weeks of post-interventionThe Canadian Occupational Performance Measure is an interview-based assessment of self-perception of performance of everyday living activities (measured on a scale from 1-10)
Developmental Assessment for Young Children, Second Edition (DAYC-2)pre-intervention (within 2 weeks of start of intervention), and within 2 weeks of post-interventionThe Developmental Assessment for Young Children is an interview and observation based norm-referenced developmental assessment (raw scores 0 or 1, converted to standard scores)
Weekly Caregiver Logweekly for 8 weeksThe caregiver log includes feasibility (time), stress, and impact on unilateral and bimanual hand function measured using a likert scale of 1-4

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026